BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4913800)

  • 1. Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid.
    Henman FD
    Gut; 1970 Apr; 11(4):344-51. PubMed ID: 4913800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of peptic activity in man by carbenoxolyne sodium.
    Berstad A
    Scand J Gastroenterol; 1972; 7(2):129-35. PubMed ID: 4553652
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibition by carbenoxolone sodium of individual human pepsinogens and pepsins.
    Roberts NB; Taylor WH
    Clin Sci; 1973 Feb; 44(2):6P-7P passim. PubMed ID: 4579239
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbenoxolone sodium.
    Sircus W
    Gut; 1972 Oct; 13(10):816-24. PubMed ID: 4564085
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein.
    Ito Y; Nakamura S; Onoda Y; Sugawara Y; Takaiti O
    Jpn J Pharmacol; 1993 Jun; 62(2):169-74. PubMed ID: 8371515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inactivation by carbenoxolone of individual human pepsinogens and pepsins.
    Roberts NB; Taylor WH
    Clin Sci Mol Med; 1973 Aug; 45(2):213-24. PubMed ID: 4206390
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of peptic ulcer with Biogastrone (carbenoxolone)].
    Brailski Kh; Dimitrov B
    Vutr Boles; 1979; 18(5):37-44. PubMed ID: 516651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective action of deglycyrrhizinized liquorice on the occurrence of stomach ulcers in pylorus-ligated rats.
    Andersson S; Bárány F; Caboclo JL; Mizuno T
    Scand J Gastroenterol; 1971; 6(8):683-6. PubMed ID: 5139109
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental and clinical studies on the action mechanism of carbenoxolone. I. Influence of carbenoxolone on the gastric juice and mucus secretion in the rat].
    Gheorghiu T; Frotz H; Klein HJ
    Verh Dtsch Ges Inn Med; 1971; 77():511-5. PubMed ID: 5155883
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antacids and antipeptic agents].
    Belousov AS; Mamedova LD; Zel'din VE; Rakitskaia LG; Loranskaia ID
    Klin Med (Mosk); 1989 Sep; 67(9):123-9. PubMed ID: 2511377
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changed composition of gastric mucosa following carbenoxolone treatment].
    Maiwald L; Weicker U
    Z Gastroenterol; 1972; 10(1):17-21. PubMed ID: 4671734
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental and clinical studies on carbenoxolone action mechanism. 3. Influence of carbenoxolone on gastric mucus secretion in man].
    Gheorghiu T; Frotz H; Klein HJ
    Verh Dtsch Ges Inn Med; 1972; 78():1415-8. PubMed ID: 4665567
    [No Abstract]   [Full Text] [Related]  

  • 13. Sucralfate: antipeptic, antiulcer activities and antagonism of gastric emptying.
    Borella LE; Seethaler K; Lippmann W
    Arzneimittelforschung; 1979; 29(5):793-8. PubMed ID: 387045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of carbenoxolone on enzymes, with special reference to the pepsins and their secretion.
    Roberts NB; Walker V; Etherington DJ; Baron JH; McConnell RB; Taylor WH
    Acta Gastroenterol Belg; 1983; 46(9-10):448-58. PubMed ID: 6424375
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of carbenoxolone Na on acute and chronic gastric ulcer models in experimental animals.
    Okabe S; Takata Y; Takeuchi K; Naganuma T; Takagi K
    Am J Dig Dis; 1976 Aug; 21(8):618-25. PubMed ID: 986116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone.
    Doll R; Langman MJ; Shawdon HH
    Gut; 1968 Feb; 9(1):42-5. PubMed ID: 5640925
    [No Abstract]   [Full Text] [Related]  

  • 17. New therapeutic agents for peptic ulcer.
    Augur NA
    J Maine Med Assoc; 1971 Oct; 62(10):245-6 passim. PubMed ID: 4937792
    [No Abstract]   [Full Text] [Related]  

  • 18. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
    Pearson JP; Roberts NB
    Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New antipeptic agents for the treatment of peptic ulcer].
    Fisher AA; Poliak RI
    Acta Anaesthesiol; 1968; 19(3):8-14. PubMed ID: 4910014
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects and mechanism of action of a lignosulphonate on experimental gastric ulceration in rats.
    Vocac JA; Alphin RS
    Eur J Pharmacol; 1968 Aug; 4(1):99-102. PubMed ID: 4878485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.